Azetidinimines as a novel series of non-covalent broad-spectrum inhibitors of β-lactamases with submicromolar activities against carbapenemases KPC-2 (class A), NDM-1 (class B) and OXA-48 (class D)
- 1 July 2021
- journal article
- research article
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 219, 113418
Abstract
No abstract availableKeywords
All Related Versions
Funding Information
- Agence Nationale de la Recherche
- Ile-de-France Regional Council
This publication has 75 references indexed in Scilit:
- Avibactam is a covalent, reversible, non–β-lactam β-lactamase inhibitorProceedings of the National Academy of Sciences, 2012
- In Vitro Activity of MK-7655, a Novel β-Lactamase Inhibitor, in Combination with Imipenem against Carbapenem-Resistant Gram-Negative BacteriaAntimicrobial Agents and Chemotherapy, 2012
- ExPASy: SIB bioinformatics resource portalNucleic Acids Research, 2012
- Characterization of an IncFII Plasmid Encoding NDM-1 from Escherichia coli ST131PLOS ONE, 2012
- Global Spread of Carbapenemase-producingEnterobacteriaceaeEmerging Infectious Diseases, 2011
- Ynamides: A Modern Functional Group for the New MillenniumChemical Reviews, 2010
- Crystal Structure of KPC-2: Insights into Carbapenemase Activity in Class A β-Lactamases,Biochemistry, 2007
- UCSF Chimera—A visualization system for exploratory research and analysisJournal of Computational Chemistry, 2004
- Improved protein–ligand docking using GOLDProteins: Structure, Function, and Bioinformatics, 2003
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973